Characteristics of Patients With Antiphospholipid Antibody Positivity in the APS ACTIONInternational Clinical Database and Repository
Title: | Characteristics of Patients With Antiphospholipid Antibody Positivity in the APS ACTIONInternational Clinical Database and Repository |
---|---|
Authors: | Sevim, Ecem, Zisa, Diane, Andrade, Danieli, Sciascia, Savino, Pengo, Vittorio, Tektonidou, Maria G., Ugarte, Amaia, Gerosa, Maria, Belmont, H. Michael, Zamorano, Maria Angeles Aguirre, Fortin, Paul R., Ji, Lanlan, Efthymiou, Maria, Cohen, Hannah, Branch, D. Ware, Jesus, Guilherme Ramires, Andreoli, Laura, Petri, Michelle, Rodriguez, Esther, Cervera, Ricard, Knight, Jason S., Atsumi, Tatsuya, Willis, Rohan, Roubey, Robert, Bertolaccini, Maria Laura, Erkan, Doruk, Barbhaiya, Medha |
Source: | Arthritis Care and Research; February 2022, Vol. 74 Issue: 2 p324-335, 12p |
Abstract: | To describe the baseline characteristics of patients with positivity for antiphospholipid antibodies (aPLs) who were enrolled in an international registry, the Antiphospholipid Syndrome (APS) Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository, overall and by clinical and laboratory subtypes. The APS ACTION registry includes adults who persistently had positivity for aPLs. We evaluated baseline sociodemographic and aPL‐related (APS classification criteria and “non‐criteria”) characteristics of patients overall and in subgroups (aPL‐positive without APS, APS overall, thrombotic APS only, obstetric APS only, and both thrombotic APS/obstetric APS). We assessed baseline characteristics of patients tested for the presence of three aPLs (lupus anticoagulant [LAC] test, anticardiolipin antibody [aCL], and anti–β2‐glycoprotein I [anti‐β2GPI]) antibodies by aPL profiles (LAC only, single, double, and triple aPL positivity). The 804 aPL‐positive patients assessed in the present study had a mean age of 45 ± 13 years, were 74% female, and 68% White; additionally, 36% had other systemic autoimmune diseases. Of these 804 aPL‐positive patients, 80% were classified as having APS (with 55% having thrombotic APS, 9% obstetric APS, and 15% thrombotic APS/obstetric APS). In the overall cohort, 71% had vascular thrombosis, 50% with a history of pregnancy had obstetric morbidity, and 56% had experienced at least one non‐criteria manifestation. Among those with three aPLs tested (n = 660), 42% were triple aPL–positive. While single–, double–, and triple aPL–positive subgroups had similar frequencies of vascular, obstetric, and non‐criteria events, these events were lowest in the single aPL subgroup, which consisted of aCLs or anti‐β2GPI only. Our study demonstrates the heterogeneity of aPL‐related clinical manifestations and laboratory profiles in a multicenter international cohort. Within single aPL positivity, LAC may be a major contributor to clinical events. Future prospective analyses, using standardized core laboratory aPL tests, will help clarify aPL risk profiles and improve risk stratification. |
Database: | Supplemental Index |
FullText | Links: – Type: other Text: Availability: 0 CustomLinks: – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edo&genre=article&issn=2151464X&ISBN=&volume=74&issue=2&date=20220201&spage=324&pages=324-335&title=Arthritis Care and Research&atitle=Characteristics%20of%20Patients%20With%20Antiphospholipid%20Antibody%20Positivity%20in%20the%20APS%20ACTIONInternational%20Clinical%20Database%20and%20Repository&aulast=Sevim%2C%20Ecem&id=DOI:10.1002/acr.24468 Name: Full Text Finder (for New FTF UI) (s8985755) Category: fullText Text: Find It @ SCU Libraries MouseOverText: Find It @ SCU Libraries |
---|---|
Header | DbId: edo DbLabel: Supplemental Index An: ejs58755471 RelevancyScore: 923 AccessLevel: 6 PubType: Periodical PubTypeId: serialPeriodical PreciseRelevancyScore: 922.567504882813 |
IllustrationInfo | |
Items | – Name: Title Label: Title Group: Ti Data: Characteristics of Patients With Antiphospholipid Antibody Positivity in the APS ACTIONInternational Clinical Database and Repository – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Sevim%2C+Ecem%22">Sevim, Ecem</searchLink><br /><searchLink fieldCode="AR" term="%22Zisa%2C+Diane%22">Zisa, Diane</searchLink><br /><searchLink fieldCode="AR" term="%22Andrade%2C+Danieli%22">Andrade, Danieli</searchLink><br /><searchLink fieldCode="AR" term="%22Sciascia%2C+Savino%22">Sciascia, Savino</searchLink><br /><searchLink fieldCode="AR" term="%22Pengo%2C+Vittorio%22">Pengo, Vittorio</searchLink><br /><searchLink fieldCode="AR" term="%22Tektonidou%2C+Maria+G%2E%22">Tektonidou, Maria G.</searchLink><br /><searchLink fieldCode="AR" term="%22Ugarte%2C+Amaia%22">Ugarte, Amaia</searchLink><br /><searchLink fieldCode="AR" term="%22Gerosa%2C+Maria%22">Gerosa, Maria</searchLink><br /><searchLink fieldCode="AR" term="%22Belmont%2C+H%2E+Michael%22">Belmont, H. Michael</searchLink><br /><searchLink fieldCode="AR" term="%22Zamorano%2C+Maria+Angeles+Aguirre%22">Zamorano, Maria Angeles Aguirre</searchLink><br /><searchLink fieldCode="AR" term="%22Fortin%2C+Paul+R%2E%22">Fortin, Paul R.</searchLink><br /><searchLink fieldCode="AR" term="%22Ji%2C+Lanlan%22">Ji, Lanlan</searchLink><br /><searchLink fieldCode="AR" term="%22Efthymiou%2C+Maria%22">Efthymiou, Maria</searchLink><br /><searchLink fieldCode="AR" term="%22Cohen%2C+Hannah%22">Cohen, Hannah</searchLink><br /><searchLink fieldCode="AR" term="%22Branch%2C+D%2E+Ware%22">Branch, D. Ware</searchLink><br /><searchLink fieldCode="AR" term="%22Jesus%2C+Guilherme+Ramires%22">Jesus, Guilherme Ramires</searchLink><br /><searchLink fieldCode="AR" term="%22Andreoli%2C+Laura%22">Andreoli, Laura</searchLink><br /><searchLink fieldCode="AR" term="%22Petri%2C+Michelle%22">Petri, Michelle</searchLink><br /><searchLink fieldCode="AR" term="%22Rodriguez%2C+Esther%22">Rodriguez, Esther</searchLink><br /><searchLink fieldCode="AR" term="%22Cervera%2C+Ricard%22">Cervera, Ricard</searchLink><br /><searchLink fieldCode="AR" term="%22Knight%2C+Jason+S%2E%22">Knight, Jason S.</searchLink><br /><searchLink fieldCode="AR" term="%22Atsumi%2C+Tatsuya%22">Atsumi, Tatsuya</searchLink><br /><searchLink fieldCode="AR" term="%22Willis%2C+Rohan%22">Willis, Rohan</searchLink><br /><searchLink fieldCode="AR" term="%22Roubey%2C+Robert%22">Roubey, Robert</searchLink><br /><searchLink fieldCode="AR" term="%22Bertolaccini%2C+Maria+Laura%22">Bertolaccini, Maria Laura</searchLink><br /><searchLink fieldCode="AR" term="%22Erkan%2C+Doruk%22">Erkan, Doruk</searchLink><br /><searchLink fieldCode="AR" term="%22Barbhaiya%2C+Medha%22">Barbhaiya, Medha</searchLink> – Name: TitleSource Label: Source Group: Src Data: Arthritis Care and Research; February 2022, Vol. 74 Issue: 2 p324-335, 12p – Name: Abstract Label: Abstract Group: Ab Data: To describe the baseline characteristics of patients with positivity for antiphospholipid antibodies (aPLs) who were enrolled in an international registry, the Antiphospholipid Syndrome (APS) Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository, overall and by clinical and laboratory subtypes. The APS ACTION registry includes adults who persistently had positivity for aPLs. We evaluated baseline sociodemographic and aPL‐related (APS classification criteria and “non‐criteria”) characteristics of patients overall and in subgroups (aPL‐positive without APS, APS overall, thrombotic APS only, obstetric APS only, and both thrombotic APS/obstetric APS). We assessed baseline characteristics of patients tested for the presence of three aPLs (lupus anticoagulant [LAC] test, anticardiolipin antibody [aCL], and anti–β2‐glycoprotein I [anti‐β2GPI]) antibodies by aPL profiles (LAC only, single, double, and triple aPL positivity). The 804 aPL‐positive patients assessed in the present study had a mean age of 45 ± 13 years, were 74% female, and 68% White; additionally, 36% had other systemic autoimmune diseases. Of these 804 aPL‐positive patients, 80% were classified as having APS (with 55% having thrombotic APS, 9% obstetric APS, and 15% thrombotic APS/obstetric APS). In the overall cohort, 71% had vascular thrombosis, 50% with a history of pregnancy had obstetric morbidity, and 56% had experienced at least one non‐criteria manifestation. Among those with three aPLs tested (n = 660), 42% were triple aPL–positive. While single–, double–, and triple aPL–positive subgroups had similar frequencies of vascular, obstetric, and non‐criteria events, these events were lowest in the single aPL subgroup, which consisted of aCLs or anti‐β2GPI only. Our study demonstrates the heterogeneity of aPL‐related clinical manifestations and laboratory profiles in a multicenter international cohort. Within single aPL positivity, LAC may be a major contributor to clinical events. Future prospective analyses, using standardized core laboratory aPL tests, will help clarify aPL risk profiles and improve risk stratification. |
PLink | https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=ejs58755471 |
RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/acr.24468 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 12 StartPage: 324 Titles: – TitleFull: Characteristics of Patients With Antiphospholipid Antibody Positivity in the APS ACTIONInternational Clinical Database and Repository Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sevim, Ecem – PersonEntity: Name: NameFull: Zisa, Diane – PersonEntity: Name: NameFull: Andrade, Danieli – PersonEntity: Name: NameFull: Sciascia, Savino – PersonEntity: Name: NameFull: Pengo, Vittorio – PersonEntity: Name: NameFull: Tektonidou, Maria G. – PersonEntity: Name: NameFull: Ugarte, Amaia – PersonEntity: Name: NameFull: Gerosa, Maria – PersonEntity: Name: NameFull: Belmont, H. Michael – PersonEntity: Name: NameFull: Zamorano, Maria Angeles Aguirre – PersonEntity: Name: NameFull: Fortin, Paul R. – PersonEntity: Name: NameFull: Ji, Lanlan – PersonEntity: Name: NameFull: Efthymiou, Maria – PersonEntity: Name: NameFull: Cohen, Hannah – PersonEntity: Name: NameFull: Branch, D. Ware – PersonEntity: Name: NameFull: Jesus, Guilherme Ramires – PersonEntity: Name: NameFull: Andreoli, Laura – PersonEntity: Name: NameFull: Petri, Michelle – PersonEntity: Name: NameFull: Rodriguez, Esther – PersonEntity: Name: NameFull: Cervera, Ricard – PersonEntity: Name: NameFull: Knight, Jason S. – PersonEntity: Name: NameFull: Atsumi, Tatsuya – PersonEntity: Name: NameFull: Willis, Rohan – PersonEntity: Name: NameFull: Roubey, Robert – PersonEntity: Name: NameFull: Bertolaccini, Maria Laura – PersonEntity: Name: NameFull: Erkan, Doruk – PersonEntity: Name: NameFull: Barbhaiya, Medha IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: February 2022 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 2151464X – Type: issn-print Value: 15290123 Numbering: – Type: volume Value: 74 – Type: issue Value: 2 Titles: – TitleFull: Arthritis Care and Research Type: main |
ResultId | 1 |